Related Experiment Video
Updated: Apr 20, 2026
06:11
Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
6.7K
Characterization of lung function impairment in adults with bronchiectasis
Wei-jie Guan1, Yong-hua Gao2, Gang Xu3
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Plos One
|November 19, 2014
Summary
Long-term bronchiectasis symptoms, Pseudomonas aeruginosa infection, and high HRCT scores indicate significant lung function impairment. Acute exacerbations notably reduce FVC and FEV1, impacting respiratory health.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Lung function impairment in bronchiectasis remains incompletely understood.
- Identifying factors associated with impaired lung function is crucial for patient management.
Purpose of the Study:
- To identify factors linked to lung function impairment in bronchiectasis.
- To compare spirometry changes during exacerbations versus convalescence after antibiotic treatment.
Main Methods:
- Recruited 142 patients with steady-state bronchiectasis.
- Collected baseline data: HRCT, sputum analysis, spirometry, and diffusing capacity.
- Monitored spirometry during acute exacerbations and convalescence in a subgroup of 44 patients.
Main Results:
- Factors associated with reduced FEV1 (≤50% predicted) included symptom duration ≥10 years, Pseudomonas aeruginosa, and high HRCT scores.
- Reduced diffusing capacity for carbon monoxide (DLCO) was linked to ≥4 bronchiectatic lobes.
- Significant reductions in FVC and FEV1 were observed during exacerbations compared to convalescence.
Conclusions:
- Significant lung function impairment in bronchiectasis correlates with HRCT abnormalities and Pseudomonas aeruginosa.
- Acute exacerbations cause notable decreases in FVC and FEV1.
- Spirometric parameters, excluding FVC and FEV1, showed less significant changes during exacerbations.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
22
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
22
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
20
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
20
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
16
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.3K
01:20COPD: Pathogenesis and Clinical Features
2.3K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.3K